Naguib YW - Search Results

1

Modified Spraying Technique and Response Surface Methodology for the Preparation and Optimization of Propolis Liposomes of Enhanced Anti-Proliferative Activity against Human Melanoma Cell Line A375.

Refaat H, Naguib YW, Elsayed MMA, Sarhan HAA, Alaaeldin E. Refaat H, et al. Among authors: naguib yw. Pharmaceutics. 2019 Oct 28;11(11):558. doi: 10.3390/pharmaceutics11110558. Pharmaceutics. 2019. PMID: 31661945 Free PMC article.

2

Design, characterization and in vivo evaluation of modified release baclofen floating coated beads.

Ibrahim M, Sarhan HA, Naguib YW, Abdelkader H. Ibrahim M, et al. Among authors: naguib yw. Int J Pharm. 2020 May 30;582:119344. doi: 10.1016/j.ijpharm.2020.119344. Epub 2020 Apr 18. Int J Pharm. 2020. PMID: 32315750

3

Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAF^V600E melanoma-bearing mice.

Mekkawy AI, Naguib YW, Alhaj-Suliman SO, Wafa EI, Ebeid K, Acri T, Salem AK. Mekkawy AI, et al. Among authors: naguib yw. Int J Pharm. 2021 Sep 5;606:120876. doi: 10.1016/j.ijpharm.2021.120876. Epub 2021 Jul 10. Int J Pharm. 2021. PMID: 34252520 Free PMC article.

4

Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo pharmacokinetics in mice.

Nakhla DS, Mekkawy AI, Naguib YW, Silva AD, Gao D, Ah Kim J, Alhaj-Suliman SO, Acri TM, Kumar Patel K, Ernst S, Stoltz DA, Welsh MJ, Salem AK. Nakhla DS, et al. Among authors: naguib yw. Int J Pharm. 2024 Jan 25;650:123693. doi: 10.1016/j.ijpharm.2023.123693. Epub 2023 Dec 9. Int J Pharm. 2024. PMID: 38081555 Free PMC article.

5

Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice.

Gaballa SA, Shimizu T, Takata H, Ando H, Ibrahim M, Emam SE, Amorim Matsuo NC, Kim Y, Naguib YW, Mady FM, Khaled KA, Ishida T. Gaballa SA, et al. Among authors: naguib yw. Mol Pharm. 2024 Feb 5;21(2):622-632. doi: 10.1021/acs.molpharmaceut.3c00774. Epub 2024 Jan 25. Mol Pharm. 2024. PMID: 38273445

6

Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation.

Naguib YW, Rodriguez BL, Li X, Hursting SD, Williams RO 3rd, Cui Z. Naguib YW, et al. Mol Pharm. 2014 Apr 7;11(4):1239-49. doi: 10.1021/mp4006968. Epub 2014 Mar 12. Mol Pharm. 2014. PMID: 24621456 Free PMC article.

7

Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.

Niu M, Naguib YW, Aldayel AM, Shi YC, Hursting SD, Hersh MA, Cui Z. Niu M, et al. Among authors: naguib yw. Mol Pharm. 2014 Dec 1;11(12):4425-36. doi: 10.1021/mp500565q. Epub 2014 Oct 27. Mol Pharm. 2014. PMID: 25314115 Free PMC article.

8

In vivo distribution of zoledronic acid in a bisphosphonate-metal complex-based nanoparticle formulation synthesized by a reverse microemulsion method.

Li X, Naguib YW, Cui Z. Li X, et al. Among authors: naguib yw. Int J Pharm. 2017 Jun 30;526(1-2):69-76. doi: 10.1016/j.ijpharm.2017.04.053. Epub 2017 Apr 26. Int J Pharm. 2017. PMID: 28455136 Free PMC article.

9

An Injectable Microparticle Formulation Provides Long-Term Inhibition of Hypothalamic ERK1/2 Activity and Sympathetic Excitation in Rats with Heart Failure.

Naguib YW, Yu Y, Wei SG, Morris A, Givens BE, Mekkawy AI, Weiss RM, Felder RB, Salem AK. Naguib YW, et al. Mol Pharm. 2020 Sep 8;17(9):3643-3648. doi: 10.1021/acs.molpharmaceut.0c00501. Epub 2020 Aug 4. Mol Pharm. 2020. PMID: 32786958 Free PMC article.

10

The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles.

Wiwatchaitawee K, Mekkawy AI, Quarterman JC, Naguib YW, Ebeid K, Geary SM, Salem AK. Wiwatchaitawee K, et al. Among authors: naguib yw. Drug Deliv Transl Res. 2022 Jul;12(7):1684-1696. doi: 10.1007/s13346-021-01065-7. Epub 2021 Oct 11. Drug Deliv Transl Res. 2022. PMID: 34635984 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page